Access cutting-edge alcohol-associated liver disease treatment through this clinical trial at a research site in Pasadena. Study-provided care at no cost to qualified participants.
Access alcohol-associated liver disease specialists in Pasadena at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alcohol-associated liver disease treatment provided free
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD. * Pemvidutide: 2.4 mg SC once weekly * Placebo: Placebo SC once weekly
Sponsor: Altimmune, Inc.
Check if you qualify for this alcohol-associated liver disease clinical trial in Pasadena, CA
If you're searching for alcohol-associated liver disease treatment options in Pasadena, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pasadena research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alcohol-associated liver disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.